ACTIVE

GYNEMED

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

-4,8 k €

+0.3% YoY

Revenue

1 k €

Equity

-22 k €

-28.3% YoY

What does GYNEMED do?

GYNEMED is a Private limited company incorporated in 1996. Its registered office is in Uccle.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0457.846.730

Incorporation

19/04/1996

Legal form

Private limited company

Registered office

Avenue Winston Churchill 62
1180 Uccle · BruxellesSee on map

Contributed capital

18 600,00 €

Latest accounts

30/06/2025

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Revenue	1 k €		–		–		–		–		–		10 k €	-62.5%	26,6 k €	-36.1%	41,6 k €	-12.5%	47,5 k €	-15.2%	56 k €	-4.2%	58,4 k €	+7.0%	54,6 k €		–		–		–		–
EBITDA	-4,8 k €	-3.2%	-4,6 k €	-156%	-1,8 k €	+16.5%	-2,2 k €	+72.2%	-7,8 k €	+60.1%	-19,5 k €	-50.3%	-13 k €	-58.7%	-8,2 k €	-207%	7,6 k €	+72.2%	4,4 k €	-71.7%	15,7 k €	+42.7%	11 k €	+1677%	617,9 €	-97.6%	25,8 k €	-6.7%	27,7 k €	-36.7%	43,7 k €	-38.5%	71,1 k €
Operating result	-4,8 k €	-3.2%	-4,6 k €	-156%	-1,8 k €	+16.5%	-2,2 k €	+74.1%	-8,3 k €	+57.9%	-19,8 k €	-28.4%	-15,4 k €	+36.8%	-24,4 k €	-69.6%	-14,4 k €	+16.5%	-17,2 k €	-664%	3,1 k €	+340%	692,8 €	+108%	-8,6 k €	-139%	22,4 k €	+1.4%	22,1 k €	-42.8%	38,6 k €	-32.7%	57,3 k €
Net result	-4,8 k €	+0.3%	-4,9 k €	-132%	-2,1 k €	+13.8%	-2,4 k €	+71.2%	-8,5 k €	+59.3%	-20,8 k €	-29.8%	-16 k €	-342%	6,6 k €	-62.9%	17,9 k €	+60.1%	11,2 k €	-67.7%	34,6 k €	+101%	17,2 k €	-24.8%	22,9 k €	-50.3%	46,1 k €	-7.1%	49,6 k €	-28.7%	69,5 k €	-26.8%	95 k €
Balance sheet
Equity	-22 k €	-28.3%	-17,1 k €	-39.7%	-12,3 k €	-20.7%	-10,2 k €	-31.5%	-7,7 k €	-1159%	730,5 €	-96.6%	21,5 k €	-95.0%	432,6 k €	+0.0%	432,6 k €	+0.0%	432,6 k €	+0.0%	432,4 k €	+0.1%	432 k €	-8.4%	471,7 k €	+0.2%	470,8 k €	+2.7%	458,6 k €	+2.7%	446,5 k €	+3.1%	433 k €
Total assets	13,5 k €	+178%	4,8 k €	-45.8%	8,9 k €	-45.0%	16,2 k €	+593%	2,3 k €	-82.2%	13,1 k €	-56.9%	30,5 k €	-93.2%	446,9 k €	-1.0%	451,2 k €	-0.1%	451,8 k €	-8.0%	491,2 k €	+0.1%	490,9 k €	-11.7%	555,8 k €	-4.5%	581,8 k €	-1.0%	587,6 k €	-4.0%	611,9 k €	-5.2%	645,7 k €
Cash	13,1 k €	+674%	1,7 k €	-81.0%	8,9 k €	-45.0%	16,2 k €	+593%	2,3 k €	-77.9%	10,6 k €	-61.8%	27,6 k €	+304%	6,8 k €	-30.4%	9,8 k €	-3.1%	10,2 k €	+49.4%	6,8 k €	-76.0%	28,3 k €	+204%	9,3 k €	-27.5%	12,8 k €	+33.7%	9,6 k €	-38.8%	15,7 k €	-28.7%	22 k €
Debts	35,4 k €	+61.3%	22 k €	+3.7%	21,2 k €	-19.7%	26,4 k €	+162%	10,1 k €	+1.0%	10 k €	+52.5%	6,5 k €	-54.2%	14,3 k €	-23.3%	18,6 k €	-3.5%	19,3 k €	-67.2%	58,8 k €	-0.2%	58,9 k €	-30.0%	84,2 k €	-24.1%	111 k €	-14.0%	129 k €	-21.6%	164,6 k €	-22.6%	212,7 k €

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 4 ended

Active mandates

BRIGITTE LEBLANC

Mandate

Active

YUCEL KARAMAN

Mandate

Active

Ended mandates

BRIGITTE LEBLANC

Director

Ended

BRIGITTE LEBLANC

Manager

Ended

YUCEL KARAMAN

Director

Ended

YUCEL KARAMAN

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/01/2026	23/12/2024	15/12/2023	16/12/2022	14/01/2022	14/01/2021
General meeting	21/01/2026	30/11/2024	20/11/2023	20/11/2022	23/12/2021	15/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	21/01/2026	27/01/2026	French	PDF
Abridged model	30/06/2024	30/11/2024	23/12/2024	French	PDF
Abridged model	30/06/2023	20/11/2023	15/12/2023	French	PDF
Abridged model	30/06/2022	20/11/2022	16/12/2022	French	PDF
Abridged model	30/06/2021	23/12/2021	14/01/2022	French	PDF
Abridged model	30/06/2020	15/12/2020	14/01/2021	French	PDF
Abridged model	30/06/2019	30/11/2019	30/12/2019	French	PDF
Abridged model	30/06/2018	30/11/2018	26/12/2018	French	PDF
Abridged model	30/06/2017	30/11/2017	19/12/2017	French	PDF
Abridged model	30/06/2016	30/12/2016	24/01/2017	French	PDF
Abridged model	30/06/2015	30/12/2015	14/01/2016	French	PDF
Abridged model	30/06/2014	30/12/2014	16/01/2015	French	PDF
Abridged model	30/06/2013	30/12/2013	28/01/2014	French	PDF
Abridged model	30/06/2012	28/12/2012	27/01/2013	French	PDF
Abridged model	30/06/2011	28/11/2011	22/02/2012	French	PDF
Abridged model	30/06/2010	18/01/2011	14/02/2011	French	PDF
Abridged model	30/06/2009	30/11/2009	17/12/2009	French	PDF
Abridged model	30/06/2008	30/11/2008	17/12/2008	French	PDF
Abridged model	30/06/2007	30/11/2007	28/12/2007	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 4 ended

Active mandates

BRIGITTE LEBLANC

Mandate

Active

YUCEL KARAMAN

Mandate

Active

Ended mandates

BRIGITTE LEBLANC

Director

Ended

BRIGITTE LEBLANC

Manager

Ended

YUCEL KARAMAN

Director

Ended

YUCEL KARAMAN

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates08/01/2024
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Registered office21/02/2020
SIEGE SOCIAL
PDF
Capital / shares24/05/2019
CAPITAL, ACTIONS
PDF
Capital / shares19/05/2014
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates18/07/2005
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates12/03/2004
DEMISSIONS, NOMINATIONS
PDF
Mandates30/12/2002
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-4,8 k €↑
2024
Annual accounts 2024-4,9 k €↓
2023
Annual accounts 2023-2,1 k €↑
2022
Annual accounts 2022-2,4 k €↑
2021
Annual accounts 2021-8,5 k €↑
2020
Annual accounts 2020-20,8 k €↓
2019
Annual accounts 2019-16 k €↓
2018
Annual accounts 20186,6 k €↓
2017
Annual accounts 201717,9 k €↑
2016
Annual accounts 201611,2 k €↓
2015
Annual accounts 201534,6 k €↑
2014
Annual accounts 201417,2 k €↓
2013
Annual accounts 201322,9 k €↓
2012
Annual accounts 201246,1 k €↓
2011
Annual accounts 201149,6 k €↓
2010
Annual accounts 201069,5 k €↓
2009
Annual accounts 200995 k €
19/04/1996
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GYNEMED

Overview

What does GYNEMED do?

Trend over 17 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline